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Introduction: Autism is diagnosed in numerous genetic and genomic developmental disorders associated with an
overlap in high-risk genes and loci that underlie intellectual disability (ID) and epilepsy. The aim of this stereological
study of neuronal soma volume in 25 brain structures and their subdivisions in eight individuals 9 to 26 years of
age who were diagnosed with chromosome 15q11.2-13.1 duplication syndrome [dup(15)], autism, ID and epilepsy;
eight age-matched subjects diagnosed with autism of unknown etiology (idiopathic autism) and seven control
individuals was to establish whether defects of neuronal soma growth are a common denominator of developmental
pathology in idiopathic and syndromic autism and how genetic modifications alter the trajectory of neuronal soma
growth in dup(15) autism.
Results: Application of the Nucleator software to estimate neuronal size revealed significant neuronal soma volume
deficits in 11 of 25 structures and their subregions (44 %) in subjects diagnosed with dup(15) autism, including
consistent neuronal soma volume deficits in the limbic system (sectors CA2, 3 and 4 in Ammon’s horn, the second and
third layers of the entorhinal cortex and in the amygdala), as well as in the thalamus, nucleus accumbens, external
globus pallidus, and Ch3 nucleus in the magnocellular basal complex, and in the inferior olive in the brainstem. The
second feature distinguishing dup(15) autism was persistent neuronal soma deficits in adolescents and young adults,
whereas in idiopathic autism, neuronal volume deficit is most prominent in 4- to 8-year-old children but affects only a
few brain regions in older subjects.
Conclusions: This study demonstrates that alterations in the trajectory of neuronal growth throughout the lifespan are
a core pathological features of idiopathic and syndromic autism. However, dup(15) causes persistent neuronal volume
deficits in adolescence and adulthood, with prominent neuronal growth deficits in all major compartments of the
limbic system. The more severe neuronal nuclear and cytoplasic volume deficits in syndromic autism found in this
study and the more severe focal developmental defects in the limbic system in dup(15) previously reported in this
cohort may contribute to the high prevalence of early onset intractable epilepsy and sudden unexpected death in
epilepsy.
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Autism is the most severe form of the developmental
disabilities known as autism spectrum disorders (ASDs),
which are diagnosed behaviorally as delayed or disrupted
development of social and communication skills, re-
stricted interests and stereotypical patterns of behavior
and activities, detected prior to 3 years of age [1]. In the
majority of individuals diagnosed with autism, the eti-
ology of the disorder is not known (idiopathic autism)
[2]. In past decade genetic etiology was identified in
about 10 % of individuals with ASD [3, 4], but recently
applied new technologies have both increased the identi-
fication of putative autism genes [5–7] and raised to ap-
proximately 25 % the percentage of children for whom
an autism-related genetic change can be identified [8].
The identification of 103 disease genes and 44 recur-
rent genomic imbalances associated with ASD reflects
the etiological heterogeneity underlying these disorders
[9]. ASD is among the clinical phenotypes of common
genetic disorders, including maternal 15q11-q13 dupli-
cations, fragile X syndrome (FMR1), Phelan-McDermid
syndrome (22q13 deletion syndrome/SHANK3 muta-
tions), Rett syndrome (MECP2 duplication syndrome),
tuberous sclerosis (TSC1, TSC2), Timothy syndrome
(CACNA1C) and cortical dysplasia-focal epilepsy syn-
drome (CNTNAP2) [9].
Autism in 15q11-q13 duplication
Maternally derived 15q11-q13 duplications [dup(15)] in-
volving the imprinted Prader-Willi/Angelman region are
detected in 1–3 % of all ASD cases [10–12]. Recent
studies indicate that 15q duplications (combined inter-
stitial and isodicentric 15q duplications) observed in 1 in
500 cases [13] are the second most prevalent genomic
aberration associated with autism, after fragile X syn-
drome, but penetrance for ASD is much higher in dup
15q11-q13 syndrome [12, 14] than in fragile X syndrome
[15–17]. Duplications range from 4 to 12 Mb and may
occur either through generation of a supernumerary isodi-
centric chromosome 15 [idic(15)] or as an interstitial du-
plication. Array-based comparative genomic hybridization
using single-nucleotide polymorphism arrays allowed sub-
classification of idic(15) samples by virtue of the lengths of
the duplicated region [18].
Most of the reported chromosome 15 duplications are
maternally derived. Larger supernumerary idic(15) chro-
mosomes, which include the 15q11-q13 region, are often
associated with intellectual disability (ID), seizures, aut-
istic behavior, hypotonia and hyperactivity [19]. A recent
study revealed that maternally derived or inherited dupli-
cations of the region between BP2 and BP3 were sufficient
to produce a phenotype on the autism spectrum in all
nine maternal duplication subjects tested [20]. Less com-
mon duplications of paternal origin have been reported inclinically asymptomatic individuals [10, 21–24], individ-
uals with clinical symptoms but without the ASD pheno-
type [20, 23, 25] and subjects with clinical alterations and
ASD phenotypes [20, 26]. In several studies of dup(15) co-
horts, autism was diagnosed without using standardized
measures of autism [27–29], but in the majority of studies,
standardized criteria were applied [10, 21, 22, 30–36]. Re-
cent reports reveal that 81 % (44/54 cases) with idic(15)
met the DMS-IV criteria for autism, and 92 % (50/54) for
ASD [12, 14].
Overlap between ASD, ID and epilepsy in genetic and
neuropathological studies
One of the most striking observations from genetic stud-
ies is the considerable overlap in high-risk genes and loci
in ASD, ID, and epilepsy [37], reflected in the association
of ASD with ID in approximately 70 % of cases, and with
epilepsy in 33 % [38]. Genetic and neuropathological
studies demonstrate that numerous causative factors act
through a similar pathophysiological mechanism, and
autism appears to be a final common pathway of behav-
ioral expression for many disorders [39–41]. Autism
neuropathology provides evidence of a broad spectrum
of developmental abnormalities and inter-individual dif-
ferences; however, the leading hypothesis proposed by
Margaret Bauman is that it is similarities that unify the
developmental abnormalities in autism [42]. Neuro-
pathological commonalities range from developmental
defects of neuronal proliferation and migration and dys-
plastic changes [43–47] to reduced size of neurons in
cortical minicolumns [48–50] and neurons in brain
structures related to autism diagnostic behavioral do-
mains [51–56], as well as abnormalities both related and
not related directly to ASD [57–61].
Hypothesis and aims
Detection of neuropathological commonalities in autism
of unknown etiology and autism associated with muta-
tions may reveal a type and topography of pathology
with a major contribution to the autistic phenotype.
Examination of an idiopathic autism cohort with an in-
creased percentage of larger brains revealed significant
reduction of neuronal soma volume in almost all subcor-
tical and cortical regions [60]. Detection of neuronal
soma volume deficit in dup(15) autism with significantly
smaller brains may strengthen the hypothesis that re-
duced volume of neuronal soma is a core pathological
feature of idiopathic and syndromic autism.
Therefore, the goal of this study is to compare patterns
of developmental alterations of neuronal soma volume in
eight individuals with dup(15) autism, eight individuals
with idiopathic autism and seven age-matched controls.
Dup(15) was selected for this study of neurodevelopmen-
tal commonalities between idiopathic and syndromic
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phenotype as well as the high prevalence of intellectual
deficits and epilepsy in people with dup(15). To provide a
global view of developmental alterations in the brains of
people with dup(15) autism and idiopathic autism, 25
brain structures and their cytoarchitectonic subdivisions
were examined, including several basal ganglia (amygdala,
thalamus, five striatum subdivisions: caudate, putamen,
globus pallidus internal and external, and nucleus accum-
bens), limbic system (Ammon’s horn, entorhinal cortex),
neurotransmitter system (magnocellular basal complex
with nuclei of the cholinergic system and substantia
nigra), cerebellum (Purkinje cells and dentate nucleus)
and the inferior olive in the brainstem.
The results of the study support the hypothesis that
abnormal neuronal size is a common developmental fea-
ture of dup(15)autism and autism of unknown etiology.
However, the study also revealed dup15/autism–specificTable 1 Material after application of exclusion and inclusion criteria
Group Case # Sex Age (y) Cause o
Dup(15) AN14762 M 9 SUDEP
autism AN06365 M 10 SUDEP
AN09402 M 11 SUDEP
AN07740 F 15 SUDEP (
AN09470 F 15 Pneumo
AN07993 F 22 SUDEP
AN05983 M 24 SUDEP
AN14829 F 26 SUDEP (
Mean ± SD 16 ± 7
Idiopathic autism HSB4640 M 8 Asthma
AN01293 M 9 SUDC
AN02736 M 15 Pneumo
AN01570 F 18 SUDEP
IBR93-01 M 23 Seizure-r
AN08166 M 28 Seizure-r
NP06-54 M 32 Glioblast
AN06420 M 39 Heart fai
Mean ± SD 21 ± 11
Control UMB1706 F 8 Cardiac
UMB1670 M 14 Asphyxia
UMB4722 M 14 Traumat
BTB-3960 F 25 Not esta
UMB4637 F 31 Traumat
IBR291-00 M 32 Heart fai
IBR212-98 F 33 Broncho
Mean ± SD 22 ± 10
PMI post-mortem interval, Dup(15) chromosome 15q11.2-13.1 duplication syndrome
death in childhood. Glioblastomaa was found as a single lesion located in the inferi
detected in the left hemisphere examined morphometricallydifferences in the topography and trajectory of neuronal
growth alterations throughout the lifespan.
Materials and methods
Cohort
Originally, 33 brains, including 11 brains of individuals
diagnosed with dup(15), 13 brains of subjects with aut-
ism of unknown etiology and nine control subjects, were
assigned to this project. However, application of the clin-
ical and neuropathological exclusion criteria reduced the
size of the cohort to 23 age-matched cases including
eight dup(15) autism, eight idiopathic autism and seven
control cases. The brain of one subject with dup(15) aut-
ism and two brains of subjects with idiopathic autism
were excluded as a result of pre-mortem hypoxia-ischemia
and encephalopathy with numerous foci of recent necrosis
(Table 1). The brain of one subject with dup(15) autism




suspected) 24.0 L 1,141
nia — L 1,125
11.8 L 1,209
36.3 L 1,200
suspected) 28.6 R 1,310
20.3 ± 9.6 1,215 ± 149
attack 13.8 R 1,740
3.7 R 1,690
nia 2.5 L 1,390
6.7 L 2,100
elated 14.0 L 1,610
elated 43.0 R 1,580
omaa — L 1,260
lure 13.9 R 1,520
14.0 ± 13.7 1,611 ± 251
transplant rejection 20.0 R 1,340
(hanging) 5.0 R 1,420
ic injuries 16.0 R 1,340
blished 26.0 L 1,520
ic injuries 17.0 L 1,354
lure 14.0 R 1,401
pneumonia 6.0 L 1,260
14.9 ± 7.4 1,376 ± 81
, SUDEP sudden unexpected death in epilepsy, SUDC sudden unexplained
or temporal gyrus of the right hemisphere. Neoplastic changes were not
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temporal lobe resulted in loss of several structures. To
concentrate this comparative study on properties of the
cohort with a double diagnosis of dup(15) and autism, one
case with dup(15) but without autism was excluded. Two
control cases were excluded, one because of detection of
clinically not symptomatic but extensive cerebellar dyspla-
sia during neuropathological examination, and the second,
because its age did not match any in the autistic cohorts.
Dup(15) is a rare developmental disorder, and the
number of postmortem studies of brains of individuals
diagnosed with dup(15) is very limited. Therefore, the
age of individuals diagnosed with dup(15), from 9 to
26 years (mean age ± SD; 16 ± 7), was the restraining fac-
tor in selection of age-matched control subjects (from 8
to 33 years; 22 ± 10) and subjects with idiopathic autism
(from 8 to 39 years; 21 ± 11). The ratio between males
and females was 4:4 in the dup(15) autism group, 3:4 in
the control group, and 7:1 in the idiopathic autism
group.
Sudden and unexplained death in patients with epi-
lepsy (SUDEP) was reported in seven of eight (87 %)
cases in the dup(15) cohort. In the idiopathic autism
group, the SUDEP was reported in one case, and death
was related to epilepsy in two other cases (total of three
cases per eight examined; 37 %). In control cases, the
cause of death was due to heart or respiratory system
failure (three cases), multiple traumatic injuries related
to car accident (two cases) or suicide (one case). In one
case, the cause of death was not established.
Chromosome 15 abnormalities in dup(15) cohort
Tetrasomy of the Prader-Willi syndrome/Angelman syn-
drome–critical region was detected in seven subjects
with dup(15). In an 11-year-old boy, a complex tricentric
supernumerary chromosome arising from nonallelic
homologous recombination between multiple copies of
BP3 rendered him hexasomic for the region between the
centromere and BP3 [62] (case 2); [63] (case 00–29). Ab-
normalities were determined as being of maternal origin
in all dup(15) cases except for a 22-year-old female with
undetermined origin of two extra copies of the 15q11.2-
q13.1 region. A more detailed description of all eight in-
dividuals diagnosed with dup(15) was published by
Wegiel et al. [46] based on reports by Mann et al. [62]
and Wang et al. [63].
Clinical characteristics and diagnosis of autism
The source of clinical data was the medical records of the
autistic subjects, which consisted of psychological, behav-
ioral, neurological and psychiatric evaluation reports. All
of the records were obtained after the subjects’ deaths.
The Autism Diagnostic Interview-Revised (ADI-R) was
administered to each donor family as a standardizedassessment tool to confirm autism diagnosis on a post-
mortem basis. The ADI-R provides scores of four do-
mains: (a) qualitative abnormalities in reciprocal social
interaction; (b) qualitative abnormalities in verbal and
nonverbal communication; (c) restricted, repetitive and
stereotyped patterns of behavior; and (d) abnormality of
development evident at or before 36 months [1].
Of the eight subjects with dup(15), diagnosis of autism
was confirmed with the ADI-R in six cases (Table 2). In
a 9-year-old boy, autism had been diagnosed with the
Autism Diagnostic Observation Schedule–Generic
(ADOS-G) before death. In an 11-year-old boy, impair-
ments were consistent with pervasive developmental dis-
order–not otherwise specified. Average scores on the
ADI-R scale, including reciprocal social interactions
(score 21 ± 7 in dup(15) autism and 24 ± 7 in idiopathic
autism); verbal deficits in communication (20 ± 3 and 17
± 6, respectively); restricted, repetitive and stereotyped
behavior (5 ± 4 and 6 ± 2, respectively); and behavioral al-
terations evident before 36 months (4 ± 1 in both groups)
reveal no significant difference between clinical autism
symptoms in the dup(15) autism and in the idiopathic aut-
ism cohorts examined postmortem.
In the examined cohort, epilepsy was diagnosed in
seven of eight (87 %) individuals diagnosed with
dup(15), including intractable early-onset epilepsy re-
ported at the age of 8 months, at 10 months in two chil-
dren, and at 7 years. In two individuals, vagus nerve
stimulator was applied, and in one subject, application
of stimulator was followed by callosotomy. In the idio-
pathic autism group, epilepsy was reported in four of
eight cases (50 %), whereas in one case, the first seizure
was the cause of death.
In the dup(15) group, intellectual deficit was reported
in six cases, including profound deficit in four individ-
uals (67 %), and severe and moderate in two other cases.
Records regarding intellectual deficit were available for
only three cases of idiopathic autism, all three of them
diagnosed with moderate ID.
Brain tissue preservation
The difference between mean postmortem intervals
(PMI, Table 1) in dup(15) autism (20.3 ± 9.6), idiopathic
autism (14 ± 13.7) and control group (14.9 ± 7.4) was in-
significant. Brains were removed using standard tech-
niques, weighed, and sagittally cut through the corpus
callosum and brainstem. The mean brain weights at aut-
opsy were 1,215 (±149) g in the dup(15) group, 1,611
(±251) g in idiopathic autism, and 1,376 (±81) g in control
group. The difference between dup(15) autism and idio-
pathic autism was significant, but differences between
control and two autistic groups were insignificant.
One brain hemisphere was fixed in 10 % buffered for-
malin for more than several months. After approximately
Table 2 Psychiatric and neurological assessment
Group Case# Psychiatric disorders, neurological symptoms Cognitive assessment Seizures (age of onset) Diagnosis of
autism
Dup(15) autism AN14762 Regression in infancy. Hypotonia.







AN06365 Severe regression at age of 15 months. Hypotonia Profound ID Intractable epilepsy (8 m) Autism (ADI-R)
(DQ = 22)




AN07740 Delay of motor skills. Moderate spastic quadriparesis.
Abnormal response to pain and heat
Severe ID Seizures (11 y) Autism (ADI-R)
(DQ = 31)
AN09470 Hyperactivity (—) No record Autism (ADI-R)
AN07993 (—) (—) Epilepsy (9 y) Autism (ADI-R)




AN14829 Obsessive compulsive behavior Moderate ID Epilepsy (16 y) Autism (ADI-R)
(IQ = 36)
Idiopathic autism HSB4640 Self-stimulatory behavior (—) Epilepsy (8 y) Atypical autism
(ADI-R)
AN01293 Hypotonia Moderate ID No record Autism (ADI-R)
AN02736 Hypotonia. Sleep disorder Moderate ID Epilepsy (2 y) Autism (ADI-R)
AN01570 (—) (—) Epilepsy (8 y) Autism (ADI-R)
IBR93-01 Hyperactivity. Aggression. Sleep disorder Moderate ID Seizure (23 y) Autism (ADI-R)
(IQ = 36)
AN08166 Bipolar disorder (—) Epilepsy Autism (ADI-R)
NP06-54 No record (—) No record Autism (ADI-R)
AN06420 Impulsivity. Aggression (—) No record Autism (ADI-R)
Dup(15) chromosome 15q11.2-13.1 duplication syndrome, ID intellectual disability, DQ development quotient, ADOS-G Autism Diagnostic Observation Schedule–
Generic, ADI-R Autism Diagnostic Interview-Revised, VNS vagus nerve stimulator
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MRI. The topography, type and size of developmental
abnormalities were determined by postmortem MRI
and neuropathological examination [46]. Brain hemi-
spheres were dehydrated in a graded series of increas-
ing ethyl alcohol concentrations for 14 days, infiltrated
with polyethylene glycol (PEG) 400 (no. 807 485;
Merck, Whitehouse Station, NJ) and stored at 4 °C.
Serial 50-μm-thick hemispheric sections were cut, and
numbered free-floating sections were stored in 70 %
ethyl alcohol. Sections were washed in water for 6–
12 h, stained with cresyl violet (CV) and mounted with
Acrytol. Neuropathological examination of approxi-
mately 140 serial sections with a 1.2-mm distance be-
tween sections revealed 2.5 times more developmental
defects of neuronal migration in the dup(15) autism
than in the idiopathic autism cohort [46].
Tissue acquisition was based on individual tissue trans-
fer agreements between the project’s principal investigator
and several tissue banks, including (1) the National
Institute of Child Health and Human DevelopmentBrain and Tissue Bank for Developmental Disorders
at the University of Maryland School of Medicine,
MD, (2) the Harvard Brain Tissue Resource Center,
McLean Hospital, Belmont, MA, and (3) the Brain
and Tissue Bank for Developmental Disabilities and
Aging of the New York State Institute for Basic Research
(IBR) in Developmental Disabilities. IBR’s Institutional
Review Board approved the methods applied in this study.
Stereological and statistical analysis
To establish the difference between neuronal size in sub-
jects diagnosed with autism caused by dup(15) and aut-
ism of unknown etiology, the volume of neuronal soma
has been estimated with the nucleator method [64]. To
identify the global pattern of developmental abnormal-
ities of neuron growth, 25 brain structures and their
subdivisions (Table 3) were examined, including amyg-
dala; thalamus and magno- and parvo-cellular lateral
geniculate nucleus; claustrum; four striatum subdivi-
sions, caudate, putamen, external and internal globus
pallidus; four subdivisions of the magnocellular basal





Obj. Grid size (μm) Test area
size (μm)





Amygdala 5 40× 2,000 × 2,000 60 × 60 133 ± 32 170 ± 5 0.01
Thalamus 6 40× 2,000 × 2,000 60 × 60 286 ± 82 219 ± 15 0.01
Entorhinal cortex (EC): Isl 3 100× 400 × 400 50 × 50 69 ± 27 107 ± 4 0.004
EC: L III 3 100× 800 × 800 50 × 50 57 ± 17 106 ± 4 0.004
Ammon’s horn: CA1 3 100× 1,000 × 1,000 50 × 50 41 ± 13 107 ± 4 0.004
CA2 3 100× 400 × 400 50 × 50 30 ± 10 106 ± 3 0.003
CA3 3 100× 400 × 400 50 × 50 44 ± 17 105 ± 3 0.004
CA4 3 100× 600 × 600 50 × 50 37 ± 15 105 ± 4 0.004
Caudate nucleus 4 63× 1,000 × 1,000 80 × 80 197 ± 70 340 ± 78 0.001
Putamen 4 63× 1,000 x 1,000 80 × 80 162 ± 75 329 ± 103 0.001
Globus pallidus 6 63× 500 x 500 60 × 60 663 ± 263 190 ± 97 0.001
Nucleus accumbens 6 63× 500 × 500 80 × 80 306 ± 100 447 ± 115 0.003
Magnocellular LGN 4 40× 500 × 500 100 × 100 211 ± 49 353 ± 33 0.001
Parvocellular LGN 4 40× 500 × 500 100 × 100 211 ± 49 353 ± 33 0.001
Claustrum 5 40× 600 × 600 60 × 60 417 ± 287 276 ± 44 0.01
Substantia nigra 8 63× 300 × 300 80 × 80 392 ± 104 231 ± 97 0.003
Magnocellular basal complex Ch1 4 63x 300 x 300 80 x 80 41 ± 12 87 ± 26 0.007
Ch2 4 63× 300 × 300 80 × 80 64 ± 16 143 ± 35 0.003
Ch3 4 63× 300 x 300 80 × 80 90 ± 39 189 ± 47 0.003
Ch4 4 63× 300 × 300 80 × 80 133 ± 49 240 ± 42 0.002
Purkinje cells 5 40× 1,800 × 1,800 180 × 180 1,118 ± 209 449 ± 28 0.001
Dentate nucleus 4 40× 1,000 × 1,000 180 × 180 178 ± 39 425 ± 28 0.002
Inferior olive 6 40× 600 × 600 80 × 80 110 ± 28 129 ± 23 0.003
Obj. objective lens, CE average predicted coefficient of error of the measured neurons (Scheaffer), LGN lateral geniculate nucleus
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the substantia nigra; four sectors of the cornu Ammonis
(CA1, 2, 3 and 4); and two layers in the entorhinal cor-
tex (islands in the second layer and layer III). In the
cerebellum, the volumes of Purkinje cells and neurons in
the dentate nucleus were estimated. In the brainstem,
the size of neurons was established in the inferior olive.
Measurements of the volume of neuronal soma
were supported with the MicroBrightfield software
(Nucleator, Stereo Investigator, version 7.003, MBF
Bioscience, Williston, VT, USA). Five points of inter-
section of the systematic randomly rotated five radii
with the cell border were marked. Measurements
were performed using a workstation consisting of an
Axiophot II (Carl Zeiss, Goettingen, Germany) light
microscope with a specimen stage with a three-axis,
computer-controlled stepping motor system (Ludl
Electronics; Hawthorne, NY, USA); and a CCD colorvideo camera (CX9000 MBF Bioscience). Borderlines
of region of interest were determined at low magnifi-
cation with Plan Apo objectives 1.25x (numerical
aperture, N.A., 0.15) or 2.5x (0.075), whereas neur-
onal soma volume was estimated with objectives 40x
(0.75), 63x (0.9) or 100x (1.3).
The number of equidistant sections examined with
Nucleator varied from three in structures with relatively
uniform cytoarchitecture to eight in structures with mul-
tiple subdivisions (substantia nigra). An optical fraction-
ator systematic random sampling scheme was supported
with Stereo Investigator (MicroBrightfield Bioscience,
Inc., Williston, VT, USA). The number of virtual
counting spaces ranged from 30 (CA2) to 663 in the
globus pallidus, but for Purkinje cells, the number of
counting spaces was increased to 1,118. To reduce a
Schaeffer coefficient of error to less than 5 %, the
number of examined neurons per region in individual
Wegiel et al. Acta Neuropathologica Communications  (2015) 3:63 Page 7 of 16case ranged from 87 in Ch2 in the MBC to 449 for
Purkinje cells. Anatomical boundaries of the exam-
ined brain structures and their subdivisions were de-
scribed in Wegiel et al. [60].
This study analyzed the effect that autism has on neur-
onal soma volume in 25 brain structures and their ana-
tomical subdivisions in age-matched samples of subjects
with autism associated with dup(15), subjects with aut-
ism of idiopathic origin, and control subjects. Any data
points more than 1.5 times the interquartile range below
the 25th percentile or an equal amount above the 75th
percentile for each structure or substructure were con-
sidered outliers and were omitted from analyses. The re-
moved data accounted for approximately 3.4 % of all
records. Following the procedure developed in our pre-
vious analyses of the effects of potential confounders in-
cluding PMI in hours, fixation time in days, brain weight
in grams, percentage brain weight loss during processing
and dehydration, duration of dehydration in days, history
of seizures, and SUDEP, analyses were controlled for
PMI (log-transformed), days of dehydration, and weight
loss during dehydration. Statistical significance of differ-
ences in mean neuronal volumes in the dup(15) autism,
idiopathic autism, and control groups were computed in
general linear mixed models using the mixed procedure
in version 13.1 of the Stata statistical package [65].
Results
Examination of serial CV-stained brain sections revealed
abnormally small neurons mixed with normal size neu-
rons, and fewer large neurons in almost all the examined
regions in individuals diagnosed with dup(15) autism
from 9 to 26 years of age. Figure 1 demonstrates smaller
neurons in the nucleus accumbens, amygdala, thalamus,
CA3 sector of the Ammon’s horn, the second layer
(islands of stellate neurons) in the entorhinal cortex and
the external part of the globus pallidus in a 24-year-old
male diagnosed with dup(15) autism. In some regions,
especially in the islands of stellate cells in the entorhinal
cortex, small neurons were arranged in clusters. Com-
parison of neurons in these brain structures in teenagers
and adults does not reveal smaller neurons in the idio-
pathic autism than in the control group. However, in
subjects with autism of unknown etiology, smaller neu-
rons were a common finding in the claustrum and mag-
nocellular basal complex.
Neuron soma abnormalities detected with nucleator
In subjects diagnosed with dup(15) autism, application
of nucleator revealed significant neuronal soma volume
deficit in 11 of 25 structures and their subregions
(44 %), including the amygdala, thalamus, nucleus ac-
cumbens, globus pallidus external, and Ch3 nucleus in
the magnocellular basal complex; and surprisinglyconsistent neuronal soma volume deficit in three sectors
(CA2, 3, 4) in the Ammon’s horn, in the second and
third layers in the entorhinal cortex, and in the inferior
olive in the brainstem (Table 4). Significant neuronal soma
volume deficit ranged from 13 % to 24 %; 12 % deficit of
Purkinje cells’ volume did not reach the significance level.
Significantly smaller volume in 11 regions and insignifi-
cantly lesser volume of neurons in another 11 regions ap-
pears to reflect developmental neuronal alterations in 88 %
of the examined structures in dup(15) autism (Fig. 2).
The pattern observed in the dup(15) autism group
compared with the control group is in striking contrast
to the pattern detected in the idiopathic autism group
compared with the control group. There was no neur-
onal volume deficit in the structures affected in the
dup(15) group, but significant deficit was detected in the
claustrum and three nuclei in the magnocellular basal
complex (Ch1, 2 and 3). In idiopathic autism, the deficit
in the volume of Purkinje cells was small but statistically
significant. Comparison between dup(15) autism and
two other groups revealed that in six regions (the amyg-
dala, parvocellular lateral geniculate nucleus, globus pal-
lidus external, in Ch1 in magnocellular basal complex,
and CA3 and 4 sectors in the Ammon’s horn), the vol-
ume of neuronal soma was less than in controls and
idiopathic autism (Table 4).
To determine whether the neuron volume deficit in the
autistic group might be due to epilepsy, seven dup(15)
cases with seizures were compared with one case without
epilepsy. Despite the extremely unbalanced number of
subjects in sub-groups, the analyses showed a significantly
smaller neuron size in the amygdala (p = 0.010) and the
CA3 (p = 0.018) for those with epilepsy. The same analyses
in the idiopathic autism group with four subjects diag-
nosed with epilepsy and four without epilepsy, showed sig-
nificantly smaller neurons in all four sectors of the CA in
subjects diagnosed with epilepsy (CA1 and 2, p = 0.001;
CA3, p = 0.006, and CA4, p = 0.015) than in subjects with-
out epilepsy. Comparison of the dup(15) group vs. the
idiopathic autism group controlling for presence of epi-
lepsy revealed essentially unmodified results. For the
amygdala the p value changes from 0.024 to 0.034; for
CA3 it changed from 0.010 to 0.64; for CA4 it changed
from 0.001 to 0.002.
Neuronal soma volume alterations demonstrated by
analysis of frequency distribution
Frequency distribution demonstrates a uniform pattern
of changes, with an increased percentage of small neu-
rons and a decreased percentage of large neurons in the
nucleus accumbens, amygdala, thalamus, CA3 and CA4
sectors in the Ammon’s horn, the islands in the second
layer in the entorhinal cortex, and the external part of
the globus pallidus in subjects with dup(15) autism
Fig. 1 Neuronal size in control, dup(15) autism and idiopathic autism. Panel of micrographs demonstrates smaller neurons in the nucleus
accumbens, amygdala (lateral nucleus), thalamus (dorsal medial nucleus), CA3 sector in the Ammon’s horn, the second layer of the entorhinal
cortex (islands of stellate neurons; ECIsl) and the external globus pallidus in a 24-year-old male diagnosed with dup(15), compared to a 32-year-old
control male and a 23-year-old male diagnosed with idiopathic autism (IAutism). Stereology revealed significant (from 17 % to 23 %) neuronal soma
volume deficit in these structures in dup(15) autism. Staining with cresyl violet. Calibration bar, 20 μm
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autism and control groups was undetectable, except in
the nucleus accumbens, with a similar shift towards
small neurons. Comparison of dup(15) autism with idio-
pathic autism shows more small neurons and fewer large
neurons in dup(15) autism in the amygdala, thalamus,
CA3 and 4, and the globus pallidus external.Box plots
Box plots distinguish dup(15) autism from the idiopathic
autism and control groups with (a) lower median neur-
onal soma volume, (b) lower range of 50 % of cell vol-
ume records (box range), and (c) lower percentage of
large neurons within the 75th percentile (Fig. 4). Box
plots reveal a striking deficit of large neurons in subjects
Table 4 The difference between the mean volume of neuronal soma in control, dup(15) autism [dup(15)A] and idiopathic autism
(iAutism) subjects
Brain structure Mean volume of neuronal soma ± SD Difference between groups (% and p<)
Control Dup(15)A iAutism Control/Dup(15)A Control/iAutism iAutism/dup(15)A
Amygdala 2,424 ± 1,157 1,861 ± 1,048 2,327 ± 1,176 −23 % (0.000) −20 % (0.024)
Thalamus 3,239 ± 1,379 2,678 ± 1,231 3,328 ± 1,430 −17 % (0.003)
Magnocellular LGN 4,397 ± 2,040 4,821 ± 1,969 4,716 ± 1,960
Parvocellular LGN 2,338 ± 855 2,395 ± 887 2,514 ± 881 +7 % (0.019) −5 % (0.016)
Claustrum 1,914 ± 764 1,584 ± 739 1,582 ± 695 −17 % (0.004)
Caudate nucleus 1,133 ± 393 1,052 ± 366 1,286 ± 380
Putamen 931 ± 325 875 ± 300 1,022 ± 306
Nucleus accumbens 1,122 ± 313 919 ± 292 1,089 ± 327 −18 % (0.003)
G. pallidus ext. 5,438 ± 2,241 4,150 ± 1,931 5,117 ± 2,160 −24 % (0.001) −19 % (0.048)
G. pallidus int. 6,670 ± 3,011 5,591 ± 2,715 6,069 ± 2,842
Magnocellular basal complex Ch1 6,252 ± 2,787 4,972 ± 2,894 4,729 ± 2,500 −24 % (0.002) +5 % (0.009)
Ch2 6,966 ± 2,813 6,117 ± 2,800 5,507 ± 2,777 −21 % (0.007)
Ch3 9,592 ± 3,619 7,820 ± 3,291 7,122 ± 3,318 −18 % (0.030) −26 % (0.000)
Ch4 11,314 ± 4,242 10,956 ± 3,890 9,949 ± 3,871
Substantia N. Dors. 9,527 ± 4,350 9,864 ± 4,403 9,162 ± 4,286
Substantia N. Ven. 11,138 ± 4,474 11,099 ± 4,607 10,417 ± 4,900
Ammon’s horn CA1 3,215 ± 1,241 2,801 ± 1,127 3,211 ± 1,233
CA2 5,204 ± 1,822 4,536 ± 1,717 5,696 ± 1,965 −13 % (0.014)
CA3 4,251 ± 1,624 3,450 ± 1,347 4,291 ± 1,596 −19 % (0.000) −20 % (0.010)
CA4 4,855 ± 1,817 3,857 ± 1,615 5,087 ± 1,825 −20 % (0.001) −24 % (0.000)
Entorhinal Cortex: LII, Islands 5,116 ± 1,960 4,102 ± 1,723 4,548 ± 1,991 −20 % (0.047)
EC LIII 2,403 ± 985 1,957 ± 885 2,311 ± 914 −19 % (0.049)
Purkinje cells 11,164 ± 3,948 9,818 ± 3,747 10,849 ± 3,934 −3 % (0.024)
Dentate nucleus 7,636 ± 4,414 6,547 ± 3,939 7,793 ± 4,541
Inferior olive 5,269 ± 1,978 4,610 ± 1,639 5,264 ± 1,883 −13 % (0.023)
dup(15) chromosome 15q11.2-13.1 duplication syndrome, LGN lateral geniculate nucleus
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range of control or idiopathic autism cases.Discussion
Our previous study of idiopathic autism revealed a sig-
nificant deficit of neuronal volume in 14 of 16 examined
cortical regions and subcortical structures in 4- to 8-
year-old autistic children, but the volume increased to
the control group level in the majority of examined
structures in teenagers and adults [60]. This comparative
study of two autistic cohorts confirmed the hypothesis
that abnormal neuronal soma growth is a common de-
velopmental defect in autism of unknown etiology and
autism associated with dup(15), but also revealed that in
the dup(15) autism cohort, the pattern of age-associated
changes of neuronal soma is different than in idiopathic
autism. The significant neuronal volume deficit detectedin 11 of the 25 brain regions examined (44 %) and the
uniform but insignificant deficit in another 11 regions
demonstrate smaller neurons in 88 % of brain regions in
9- to 26-year-old individuals with dup(15) autism but
not in idiopathic autism. The detected deficit of neur-
onal soma volume in teenagers and young adults with
dup(15) autism appears to be a sign of a permanent de-
fect driven by 15q11-q13 duplications.Study limitations
Clinical records reveal autism in 81 % and ASD in 92 %
of subjects with dup(15) [12, 14]. A similar prevalence of
autism (eight of nine cases; 89 %) in a postmortem-
examined group does not allow determination of the dif-
ference between the pattern of pathology in subjects
with dup(15) with and without autism. Examination of





























































Fig. 2 Neuronal soma volume deficit in dup(15) autism. Comparison of neuronal soma volume between dup(15) autism and control subjects
revealed a significant neuronal soma volume deficit in affected subjects in 11 brain structures or their subdivisions (marked with arrows) per 25
examined (44 %), but a trend to lower cell soma volume is reflected in the insignificantly lower soma volume in another 11 brain structures in
dup(15) autism cases from 9 to 26 years of age
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subject 02–09 [63], severe ID, cerebral palsy, and intract-
able epilepsy with the onset of seizures at the age of
9 years revealed the lowest brain weight in the examined
dup(15) group [890 g; 27 % less than in dup(15) autism
(1,215 g)] and five types of focal developmental abnor-
malities (two types of heterotopias in the hippocampus
and three types of dysplasia in the dentate gyrus) similar
to the type, topography and prevalence of alterations de-
tected in eight individuals with dup(15) with autism. Ste-
reology revealed that in the majority of examined brain
structures, the volume of neuronal soma was close to
the average volume detected in the dup(15) autism
group. The type and topography of neuropathological
changes in this case was similar to those in eight cases diag-
nosed with dup(15) and autism. However, severe micro-
cephaly and the spectrum and severity of clinical alterations
distinguished this case from eight other cases and ham-
pered, but did not exclude, the diagnosis of autism. In sum-
mary, this cohort does not allow identification of the
neuropathological profile of dup(15) without autism.
The second factor limiting this comparative study is
the narrow age range (9–26 years) in the dup(15) group.
Our previous study revealed opposite trajectories of
neuronal volume changes throughout the lifespan in the
idiopathic autism and control groups. The significant
neuronal volume deficit detected in 14 of 16 examined
brain regions in 4-to 8-year-old children with idiopathic
autism decreases to four regions in the 23- to 60-year-
old autistic subjects when compared to the control
group. However, this shift is in part the result of a
physiological decrease in neuronal volume in the major-
ity of examined brain structures and their subdivisions
in the control cohort [60]. Due to the limitation of the
age range to 9–26 years in the dup(15) group, this study
demonstrates a different trajectory of neuronal growthin adolescents and young adults with dup(15) autism,
but neuronal volume alteration in early childhood and
late adulthood cannot be determined in this cohort.
Moreover, the sampling for this study does not allow for
conclusions regarding the neocortex.
The next factors that may affect conclusions from this
postmortem study of a cohort diagnosed with dup(15)
autism is 87 % prevalence of the epilepsy, the 50 %
prevalence of intractable epilepsy and the 87 % preva-
lence of SUDEP whereas an electronic survey of dup(15)
families revealed 63 % prevalence of epilepsy [66]. One
may assume that SUDEP is associated with more com-
mon and more severe developmental pathology causing
intractable epilepsy, especially a high prevalence of focal
developmental abnormalities. As a result, this cohort
and the detected pattern of developmental abnormalities
reflects pathology typical for dup(15) autism with high
prevalence of epilepsy and intractable epilepsy.
This study of postmortem material and clinical records
preserved in past 14 years is based on postmortem ADI-
R [1] diagnostic criteria and interpretation is centered
on reports published before implementation of DSM-5
[67]. The majority of comparative studies evaluating
clinical cohorts according to both DSM-IV-TR and
DSM-5 ASD criteria indicate that only between 50 %
and 75 % of individuals will maintain ASD diagnosis
when new criteria are applied [68].
Regional abnormal neuronal growth and focal
developmental abnormalities in dup(15)/autism as major
factors contributing to clinical phenotype
Table 5 summarizes the similarities and differences be-
tween clinical and neuropathological findings in idio-
pathic autism and syndromic autism caused by dup(15).
The difference between dup(15) autism and idiopathic
autism is not limited to the persistent deficit of neuronal
Fig. 3 Neuronal soma volume frequency distribution. Comparison of neuronal soma frequency distribution in dup(15) autism group (9–26 years
old), idiopathic autism (IA) group (8–39 years old) and control group (8–33 years old). Graphs arranged in order from the smallest to the largest
neurons demonstrate a significant (asterisks) shift towards small neurons in the nucleus accumbens (Acc), amygdala (Amy), thalamus (Th), CA3
and CA4 sectors in the Ammon’s horn, second layer in the entorhinal cortex (EC2) and the globus pallidus external (GPEx) in the dup(15) group
(segment-line) in comparison to age-matched control subjects (continuous line). However, at this age, the difference in neuronal body volume
distribution in these structures is not significant when subjects with idiopathic autism (IA) (dot-line) are compared to control subjects (C). The shift
to smaller neurons was significant in the dup(15)/A cohort when compared with IA in the amygdala, CA3 and CA4 sectors, and the globus pallidus
external. A similar shift in the thalamus did not reach significance level but is consistent with the trend observed in other structures
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Fig. 4 Neuronal soma volume distributions. Box plots illustrate neuronal body volume distributions in 10 structures with significantly smaller
neurons (marked with a star) in 8- to 26-year-old autistic individuals with dup(15) compared to age-matched control subjects. Purkinje cells and
neurons in the dentate nucleus were also smaller, but the difference did not reach the level of significance. Volume measures on the Y axis
correspond to x1000 of μm3. The upper and lower boundaries of each box represent the interquartile range (IQR), whereas the whisker above
and below each box marks the maximum and minimum values unless any data point lies more than 1.5 times of the IQR above the 75th percentile or
1.5 times below the 25th percentile. The characteristic features of neuron volume distribution in the dup(15) autism group in all 12 structures were
lower median values (marked with horizontal line within box), lower range of 50 % of data (box range), and fewer large neurons (much
lower maximum values marked by whiskers above the box). A few neurons in range above the 75th percentile are indicated by circles;
however, as a result of much lower maximum values outliers occur more often in dup(15) autism
Wegiel et al. Acta Neuropathologica Communications  (2015) 3:63 Page 12 of 16volume in teenagers and adults with syndromic aut-
ism. Focal developmental abnormalities of neuronal
proliferation, dysplastic changes and defects of neur-
onal migration are present in almost all examined
subjects in these two cohorts, but the number of focal de-
velopmental defects is several times higher in dup(15) aut-
ism cases. Moreover, the topography of focal alterations isdifferent, with a striking concentration in the hippocam-
pus (alveus, dentate gyrus, Ammon’s horn) found in 89 %
of dup(15) autism cases, but a low prevalence (10 %) in
idiopathic autism cases, and the opposite pattern in the
cerebral cortex, with focal dysplastic changes in 10 % of
dup(15) autism cases and in 50 % of idiopathic autism
cases [46].
Table 5 Comparison of results of clinical and neuropathological studies of idiopathic autism and dup(15) autism
Clinical and structural alterations Dup(15) autism Idiopathic autism
Autism prevalence
and severity
Clinical data 81 % of subjects met criteria for autism
and 92 % for ASD [12, 14]. Autism
diagnosed in 69 % of subjects [36]
Mild 55 %; Moderate 30 %, Severe 15 % [84]
Postmortem study Autism diagnosed in 89 % of
children and young adults
100 %
Intellectual disability Clinical data 5/5 severe-moderate ID [85, 86] IQ < 70, 31 %; IQ 71–85, 23 %; IQ > 85, 46 % [84]
Postmortem study Profound, ID in 67 %;
severe & moderate ID in 33 %
Moderate in 3 cases with tested IQ
Epilepsy Clinical data Epilepsy in 63 % [66] Epilepsy in 33 % [71]. Epileptiform activity
in 31 % of autistic children without epilepsy [75]
Postmortem study Epilepsy in 87 % including
intractable epilepsy in 62 %.
SUDEP in 87 % of cases
Epilepsy in 50 % of subjects
SUDEP in one case/eight (12 %)
Brain weight Postmortem study 1,215 g 1,611 g (1,376 g in control subjects)
Focal developmental
defects [46]
Heterotopias (alveus, CA4, DG) 89 % 10 % (p < 0.001)
DG dysplasia 89 % 10 % (p < 0.001)
Cerebral cortical dysplasia 0 % 50 % (p < 0.03)
Cerebellar heterotopias 56 % 60 % (ns)
Cerebellar flocculus dysplasia 75 % 50 % (ns)
Subependymal nodular dysplasia 22 % 10 % (ns)
Neuronal soma volume deficit
(compared to control in Wegiel et al.
[60] and current study)
- In 14/16 (87 %) regions in 4 to 8 years old [60]
11/25 (44 %) regions in 9 to 26 years old In 3/16 (19 %) regions in 11 to 23 years old [60]
- In 4/16 (25 %) regions in 22 to 49 years old [60]
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the hippocampus in dup(15) autism coincides with a
very uniform and significant deficit of neuronal soma
volume in three sectors of the Ammons horn (CA2,
13 %; CA3,19 %; and CA4, 20 %) and an insignificant
deficit in the CA1 sector. Strikingly small neurons and
clustering of small neurons in CA1 and CA4 sectors are
similar to the morphology of small neurons in the dis-
tinct foci of microdysgenesis detected in other parts of
these sectors. This pattern suggests morphological and
possibly, etiological, continuity between the diffuse pat-
tern of abnormal growth of neurons and the focal micro-
dysgenesis with small neurons in the dup(15) autism
cohort. Similar consistency of significant diffuse deficit
of neuronal volume and focal clustering of small neu-
rons as in microdysgenesis was found in the entorhinal
cortex, including islands of stellate neurons (−20 %) and
pyramidal neurons in layer III (−19 %). Axons of these
neurons form a perforant pathway projecting to the den-
tate gyrus, which demonstrates extremely prominent
multiple and diverse developmental defects, including
hyperconvolution of the dentate gyrus, focal thickening
or thinning of granular layer, fragmentation of granular
layer resulting in formation of multiple detached islands
of granular neurons, duplication of the granular layer,protrusions of the granular neurons into the molecular
layer and ectopias of granular neurons in the molecular
layer of the dentate gyrus and in the CA4 sector [46].
The perforant pathway, composed of glutaminergic fi-
bers, has an excitatory action on the granular neurons in
the dentate gyrus and directly on neurons in the CA1,
CA2 and CA3 sectors. The next link in this network is
the dentate gyrus, with glutaminergic axons of granular
neurons, which stimulate the dendrites of neurons in the
CA3 and CA4 sectors, whereas axons of CA3 and CA4
neurons (Schaffer collaterals) reach the apical dendrites
of CA1 sector [69]. These data reveal that all portions of
the perforant pathways integrating structurally and func-
tionally the entorhinal cortex and hippocampus are
characterized by abnormal neuronal growth and focal
microdysgenesis affecting connectivity in the limbic
system. The third factor contributing to limbic system
dysfunction appears to be the combination of (a) ab-
normal growth of neurons in the amygdala, resulting
in a significant—23 %—deficit of neuronal volume de-
tected in this study, and (b) multifocal microdysgenesis in
the amygdala, with the mixture of very small neurons and
abnormally large neurons reported previously [46].
These findings demonstrate the simultaneous occur-
rence of (a) developmental defects of neuronal growth in
Wegiel et al. Acta Neuropathologica Communications  (2015) 3:63 Page 14 of 16three major components of the limbic system, the ento-
rhinal cortex, hippocampus and amygdala, and (b) focal
developmental defects of neuronal migration and micro-
dysgenesis in several subdivisions of the hippocampal
formation and amygdala, which might be etiologically
linked. The combination of both types of developmental
abnormalities may contribute to the early onset of in-
tractable seizures and SUDEP reported in the six of eight
individuals (75 %) with dup(15) autism examined in this
postmortem study. The absence of neuronal volume def-
icit in the majority of limbic system subdivisions in the
age-matched idiopathic autism group, several times less
often focal developmental defects, and the lower preva-
lence of SUDEP (in one of eight cases) in idiopathic aut-
ism suggest similar core pathology but different
subpatterns in autism of unknown origin and syndromic
autism caused by dup(15).
Contribution of epilepsy to cognitive deficits and
worsening autistic behavior
In autism, epilepsy is a dynamic disorder that affects
brain development and function and changes clinical
phenotype. After a first peak in early childhood, result-
ing in 12 % prevalence in the ASD cohort from 2 to
17 years of age, the prevalence increases to 26 % in chil-
dren older than 13 years of age [70] and 30–39 % in co-
horts that include a high number of adolescents and
adults with autism [71–73]. Recently there has been in-
creasing interest in the occurrence and role of epilepti-
form activity in autism in the absence of epilepsy [74].
Sleep electroencephalograms reveal epileptiform activity
in 31 % of 36-month–old children diagnosed with aut-
ism [75], whereas continuous video-EEG telemetry de-
tects epileptiform activity in 19 of 32 (59 %) children
from 2 to 13 years of age diagnosed with autism without
seizures. Moreover, interictal epileptiform EEG abnor-
malities have been detected in 11 (73 %) of the 15 sub-
jects with autism without epilepsy [76]. Widespread
neuropathological changes detected postmortem and
growing evidence from functional and structural imaging
may show that epileptiform activity is a common devel-
opmental abnormality that is more prevalent than clinic-
ally diagnosed epilepsy [74].
The developmental regression observed usually be-
tween 12 and 24 months of age occurs in up to 33 % of
children with autism [38, 77]. Developmental regressions
have been detected not only in idiopathic autism but
also in 63 % of dup(15) subjects with epilepsy [66]. Epi-
lepsy, autism and IDs may be related to a common brain
pathology [78]. Individuals with both autism and more
severe cognitive impairment are at higher risk of epi-
lepsy [79]. Most studies revealed an association between
low IQ and increased prevalence of epilepsy in autism
[80–82]. Meta-analysis of 10 studies demonstrated ahigher pooled epilepsy prevalence rate in an autistic co-
hort with than without ID [83]. Defects of neuronal
growth in almost all examined regions in idiopathic aut-
ism [60] and in dup(15) autism with a high prevalence of
epilepsy and ID might be a marker of global developmen-
tal encephalopathy and of the involvement of similar
pathomechanisms contributing to autism, ID and epilepsy.
Conclusions
Alterations of neuronal growth trajectory throughout
the lifespan are a core pathology in idiopathic autism
and in autism caused by dup(15). The study suggests
that different topography and severity of developmental
abnormalities, including increased prevalence of focal
developmental abnormalities in the limbic system and
prominent deficit of neuronal soma volume in the
hippocampus, entorhinal cortex and amygdala may con-
tribute to the high prevalence of IDs, the early onset of
intractable epilepsy and the high rate of SUDEP in
dup(15) autism.
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